AI Insight
Researchers analyzed genomic, transcriptomic, and gene regulatory data from a large cohort of autistic individuals to test whether "profound autism" represents a biologically distinct subtype. They found no molecular evidence supporting profound autism as a separate genetic or biological category within the autism spectrum. Instead, the main biological differences observed were in gene regulatory networks between speaking and nonspeaking autistic children, suggesting that speech ability may be a more scientifically meaningful distinction than the broader profound autism classification.
Why it matters
This research challenges the validity of grouping severely impaired autistic individuals into a single "profound autism" category for research and policy purposes. The findings suggest that targeting specific traits like speech impairment, rather than attempting to define broad subtypes, may lead to more effective research strategies and personalized interventions for autistic individuals with significant support needs.
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
The Lancet Commission on the Future of Care and Clinical Research in Autism proposed the construct of "profound autism" as a recognizable subtype of autism. Supporters argue that this classification is necessary to ensure that autistic persons with severe impairment receive appropriate research attention and policy support, whereas critics contend that the construct lacks scientific validity and may reflect social or political considerations more than biological distinction. To inform this debate, we evaluate whether the proposed "profound autism" category represents a distinct genetic phenotype using multiple molecular data types collected in a large cohort. Across genomic, transcriptomic, and regulatory analyses, we find no evidence supporting "profound autism" as a biologically distinct phenotypic group. Instead, differences emerge primarily in inferred gene regulatory networks distinguishing nonspeaking from speaking autistic children, suggesting potential regulatory mechanisms contributing to speech ability. These findings suggest that future research into severe impairment may be more productive if focused on specific traits — such as speech impairment — rather than attempting to define a distinct biological subtype within the multidimensional phenomenon of autism.